Overexpression of epidermal growth factor receptor(EGFR) has been consistently observed in many human epithelial cancers, including gastric, colorectal, bladder, pancreatic, ovarian, lung, and breast cancers (11), making EGFR a validated target for cancer diagnosis and therapy (12, 13). The gene discussed is EGFR; the disease is breast carcinoma.